T he estimated risk of mortality from cardiovascular events in patients treated by dialysis is more than 10 times the risk of age-matched individuals in the general population, 1 and models developed for cardiovascular disease risk prediction in the general population may not be as accurate in hemodialysis patients. 2 Possible contributing factors include alterations in calcium/phosphate homeostasis, abnormal lipid metabolism, prevalence of hypertension and diabetes, and chronic inflammation. [3] [4] [5] [6] Noninvasive radiographic imaging is gaining recognition as a simple and valid method of improving estimations of cardiovascular risk based on the extent and grade of coronary artery calcification (CAC) in the general population 7, 8 and also in selected dialysis populations. 9, 10 The importance of vascular calcification as a prognostic tool has already been recognized by the KDIGO (Kidney Disease: Improving Global Outcomes) group, which in a position statement in 2006 recommended screening by lateral abdominal radiographs for the presence of vascular calcifications in all incident dialysis patients.
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In the general population, multidetector row computed tomography (CT) has become the predominant modality for estimating CAC 12 because calcification on these scans adds prognostic information that is independent of that included in the Framingham risk score for cardiac events and all-cause mortality. 13 In recent years, much less attention has been paid to conventional chest radiographs as an imaging modality for evaluating coronary calcifications. Although generally known to be much less sensitive than CT for CAC detection in the general population, 14 when used in a patient population with a high pretest probability for CAC, such as the hemodialysis population, conventional chest radiographs, obtained in virtually all US patients at the initiation of dialysis therapy, may serve as a valuable and readily available source of prognostic information regarding future cardiovascular events. Furthermore, if the presence of detectable calcifications on conventional chest radiographs provides important information, the much higher radiation exposure required for CT could be avoided in this population, which already undergoes many diagnostic radiology tests. 15 We hypothesized that evaluation of conventional chest radiographs for CAC in hemodialysis patients would show an association with all-cause mortality. We further postulated that CAC would serve as a prognostic indicator in its own right after adjustment for aortic arch calcification (AAC) on chest radiographs, which previously has been shown to be a risk factor for mortality in dialysis patients.
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METHODS
Participants
We identified all patients who underwent maintenance hemodialysis at the Veterans Affairs (VA) San Diego Healthcare System between May 2009 and September 2010 (N ϭ 99). Patients were included if they had a frontal and lateral chest radiograph at the VA Medical Center and if they had routine surveillance blood laboratory measurements performed during the study period.
Exclusion criteria included chest radiographs in which the presence of stents precluded accurate evaluation for CAC (n ϭ 4) and absence of a prior frontal and lateral chest radiograph (n ϭ 2).
The study protocol was reviewed and approved by the University of California San Diego Institutional Review Board and the VA Research Service. Requirement for patient consent was waived due to the use of retrospective data and minimal participant risk.
Measurements
A radiologist specializing in thoracic radiology and blinded to patient information independently reviewed one preselected frontal and lateral chest radiograph obtained from each hemodialysis patient within or as close to the prespecified study period as possible. Chest frontal and lateral views were obtained with 140 kVp on a direct digital radiography chest unit (Philips Digital Diagnost; Koninklijke Philips Electronics, www.usa.philips. com/index.page). The lateral view was inspected for potential coronary calcifications in characteristic locations pertaining to the course of the coronary arteries. In the frontal projection, the previously designated CAC triangle 14 was surveyed for visible CAC. The CAC triangle refers to a triangular region of the frontal chest film demonstrated to be valuable for visualization of CAC. It is the region outlined by the vertebral column as the medial border, the upper half of the left lateral cardiac margin as the hypotenuse, and a horizontal line as the inferior border ( Fig 1A) . CAC is readily distinguishable from epicardial calcifications because the latter tend to conform to the external cardiac contour, are thin and curvilinear, and do not conform to the anatomical course of the coronary arteries in either the frontal or lateral projection. The aortic arch was inspected for the presence of calcifications on the frontal view for AAC.
Intrareader reliability was assessed by repeated evaluation by the same radiologist of 20 chest radiographs randomly selected from the original data set. This review occurred 6 weeks after the initial reading. Agreement was assessed using statistics, which estimate the agreement beyond that expected due to chance alone. A value of zero for suggests the result is as expected due to chance, and a value of 1 suggests perfect agreement.
Covariates
Serum creatinine was measured using the enzymatic method by a Roche Diagnostics Cobas 6000 machine (Roche Elecsys Systems, www.roche-diagnostics.co.in/Products/Pages/RocheElecsysSystems. aspx). Coefficients of variation were Ͻ2%. Blood specimens were obtained previously as part of routine monthly laboratory assessments and delivered directly to the clinical laboratory on site at the same facility as our dialysis unit. Serum albumin, urea nitrogen, lipids, calcium, and phosphorus were measured predialysis on the midweek dialysis session (Wednesday or Thursday) by using routine laboratory methods. Intact parathyroid hormone was measured using the Elecsys assay (Roche Elecsys Systems), a 2-step sandwich immunoassay (reference range, 15-75 pg/mL). Age, sex, race, history of diabetes, stroke, peripheral arterial disease (PAD), angioplasty, stent placement, coronary artery bypass graft surgery; and smoking were obtained through chart review. Coronary artery disease (CAD) was defined as history of coronary artery bypass graft, angioplasty, or stent placement as determined through chart review. Hyperlipidemia was defined as total cholesterol level Ͼ200 mg/dL or use of any lipid-lowering medication. Dialysis vintage was determined from the date of maintenance hemodialysis therapy initiation recorded in the VA dialysis unit records. Systolic and diastolic blood pressures were measured with an automated sphygmomanometer prior to maintenance dialysis. Predialysis weights were measured by scale at each dialysis session. Height was obtained from the most recent value recorded in the medical record. Body mass index was calculated by postdialysis mass in kilograms divided by the square of height in meters.
Outcome
Patient deaths during the study period were determined from review of the VA computerized medical record, which includes deaths that occur at outside hospitals or at home, in addition to dates and circumstances of death. We had 100% ascertainment for death for the 93 study participants.
Statistical Methods
Participant characteristics were compared between groups with or without CAC visible on chest radiographs. Descriptive statistics were calculated using mean Ϯ standard deviation or median (25th-75th percentile) for skewed variables. P values for 2 , t test, or Mann-Whitney U test (for skewed variables) were computed as appropriate. We considered covariates for inclusion in our multivariate models based on differences between the 2 groups with P Ͻ 0.10 or biological plausibility. We limited the number of covariates in final models to no more than 6 to avoid model overspecification.
We examined Kaplan-Meier plots of survival with Hall-Wellner bands 17 based on CAC or AAC categories. Cox proportional hazard regression models were constructed to evaluate the independent hazard associated with CAC or AAC. The assumption of proportional hazards was verified by examination of negative log-log survival curves. Because of the limited number of outcomes in this data set, we proceeded with limited covariate adjustments as follows. Our first model included CAC adjusted for demographic variables (age and race). Our second model was adjusted for the risk factors traditionally associated with cardiovascular morbidity, including age, CAD, diabetes, hyperlipidemia, and hypertension. Our third model was adjusted for dialysisspecific factors associated with mortality, including age, serum phosphorus level, albumin level, dry weight, dialysis vintage, and predialysis creatinine level. We then considered mutual adjustment of CAC for AAC in a joint model, also adjusting for factors independently associated with mortality based on univariate analysis. This included age, CAD, diabetes, phosphorus level, hyperlipidemia, and predialysis creatinine level.
All analyses were conducted using SAS statistical software, version 9.3 (SAS Institute, Inc, www.sas.com).
RESULTS
Overall, 24.7% (n ϭ 23) of the cohort had visible CAC on chest radiographs and 58% (n ϭ 54) had AAC. During a median 1.8 years of follow-up, 26 deaths occurred in the study population. Representative examples of CAC and AAC on chest radiographs are shown in Fig 1B-D . Average age of maintenance hemodialysis patients with CAC was 66 Ϯ 11 years versus 63.3 Ϯ 10 years for those without CAC (P Ͻ 0.01; Table 1 ). Only 3 patients were women, reflecting the sex distribution of our VA hemodialysis population. CAD was present in 70% of patients with CAC and 39% of patients without CAC (P ϭ 0.009). Peripheral arterial disease was present in 48% of patients with CAC compared with 20% of patients without CAC (P Ͻ 0.01). There were no significant differences between CAC groups in prevalence of hyperlipidemia, smoking, diabetes, serum albumin level, dialysis vintage, or predialysis creatinine level.
Participants with CAC or AAC were at greater risk of death in unadjusted analysis (Figs 2 and 3 ; P Ͻ 0.001 for each). In Cox regression, CAC presence conferred a nearly 3-fold risk of death in a model adjusted for age and ethnicity (model 1), as listed in Table 2 . With adjustment for traditional cardiovascular risk factors (model 2), the risk was greater than 2-fold. In a third model adjusting for dialysis-related factors (age, phosphorus level, predialysis creatinine level, albumin level, body mass index, and dialysis vintage), CAC was also associated with an approximately 3-fold higher death risk. In a final model (model 4; Table 2 ) that included covariates that were associated with mortality in univariate analysis (Table 3) , the association of CAC with death was slightly stronger and remained highly statistically significant.
We evaluated AAC prevalence with mortality through the same sequence of models. Based on point estimates, AAC consistently was associated more strongly with death than CAC, with hazard ratios ranging from 5-to 7-fold higher risk compared with those without AAC (Table 3) .
When CAC and AAC were entered into models jointly, both variables remained associated with death independent of one another, albeit the point estimates were modestly attenuated compared with models that included CAC or AAC separately (Table 3) .
Of the 20 radiographs selected for repeated evaluation for CAC, 16 (80%) received a consistent evaluation ( ϭ 0.54), indicating moderate agreement. 18 On repeated evaluation for AAC, 20 of 20 received a consistent evaluation ( ϭ 1), indicating perfect agreement.
DISCUSSION
In our single-center cohort, we found a high prevalence of CAC visible on chest radiographs. This finding was associated with a 2-to 3-fold greater risk of all-cause mortality that was not attenuated by adjustment for standard cardiovascular or dialysisrelated risk factors or the presence of AAC. AAC also was highly prevalent on chest radiographs and was associated even more strongly with death. To our knowledge, this is the first study to show that CAC observed on conventional chest radiography is associated independently with mortality in hemodialysis patients.
It is known that CAC is much more common in patients with hemodialysis than their age-and sexmatched counterparts in the general population.
19
Previous studies have suggested that the prevalence of CAC in hemodialysis patients 20, 21 is much greater than 50%. Goodman et al 9 showed that 14 of 16 hemodialysis patients aged 20-30 years had coronary calcification detectable by electron-beam CT. Furthermore, CAC scores increase in fewer than 2 years in many hemodialysis patients. 22 Although calcifications in these studies were evaluated using CT, this information provides a conceptual framework for understanding the highly prevalent and progressive nature of CAC in hemodialysis patients. It also highlights the utility of assessment for the disease. Our study has shown that a simple qualitative assessment of chest radiographs for CAC is associated with substantially increased risks of mortality, even after adjustment for common confounders. Our cohort had a CAC prevalence of 25%, much less than what has been described in studies using CT in dialysis patients, although our cohort predominantly comprises older men. This suggests, as we expected, that chest radiographs are less sensitive for CAC detection; however, the high mortality rate in those with CAC in our study suggests that CAC visible on chest radiography may be more severe, and that this technique may be more specific in detecting clinically significant disease in this patient population.
Our findings are consistent with prior studies evaluating the association between various anatomic regions of arterial calcifications and mortality in hemodialysis patients, including abdominal aortic 23 and peripheral vascular calcifications 24 as assessed by conventional radiography of the abdomen and extremities. The advantage of using conventional chest radiographs is that in many cases hemodialysis patients have already had at least one (if not multiple) such study for other indications, frequently simply as a requirement for entry into a dialysis unit. 25 Thus, chest radiographs obtained in the course of usual clinical practice may be a good substitute for lateral abdominal radiograph to fulfill the NKF-KDIGO (National Kidney Foundation's Kidney Disease: Improving Global Outcomes) vascular screening recommendation.
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Electron beam CT has been studied previously in hemodialysis patients, and multidetector row CT is being used increasingly for cardiovascular risk assessment. However, the appropriate clinical indication for its use in hemodialysis patients is debatable. The American College of Cardiology Foundation/American Heart Association consensus statement 26 on CAC scoring in patients with end-stage renal disease deemed the indications for CT "unclear" due to limited available clinical studies and outcomes data. This ambiguity strengthens the argument that conventional chest radiography may serve as a reasonable alternative until the role of CT is better defined. Financial implications also deserve consideration because the cost of a chest radiograph is approximately 10%-15% of the cost of CT. 27 Furthermore, CT may not be as easily accessible in certain regions or health care systems as in the United States. 28 CT used in CAC scoring varies in the radiation dose, with estimations of 1-6.2 mSV depending on the type of CT and scanning protocol used. A frontal and lateral chest radiograph exposes the average patient to 0.06 mSv of radiation, 29 thus approximately 2 orders of magnitude less than chest CT. In addition, the cumulative radiation dose that maintenance hemodialysis patients receive, likely related to multiple chronic illnesses, is substantial and is greater than that of the general population. 15, 30 Radiation exposure may be particularly relevant in this patient population, which is potentially at higher risk of the development of malignancies. 31 Given the suggestion of a link between disordered mineral and bone metabolism and increased risk of 11 Given the ubiquity of chest radiographs in dialysis patients and the strong associations of both CAC and AAC with death observed here, chest radiographs may serve as a readily available and costeffective alternative. However, lateral abdominal radiographs may be more sensitive for vascular calcification because only ϳ25% of our patients had CAC on chest radiograph and 58% had AAC, whereas the prevalence of vascular calcification on lateral abdominal radiograph was higher (57%-81%) in prior studies 23,33 of hemodialysis patients. Future studies are needed to compare the prevalence of calcification in a single representative cohort and determine which anatomic location is associated most strongly with future mortality and CVD events. Of note, although it is speculated that hyperphosphatemia is related to CV calcifications, 16 a lower rather than higher phosphorus level was associated with mortality in our cohort, which likely is related to its role as a surrogate marker for malnutrition. 34 We confirm findings of previous studies showing strong associations of AAC on chest radiographs with mortality. [35] [36] [37] However, we extend these findings by showing for the first time that AAC and CAC are each associated independently with mortality. If confirmed, this finding suggests that multiple radiographs (chest and abdomen, for example) may be helpful to measure the systemic burden of calcification to optimize risk stratification in high-risk dialysis patients. Furthermore, given the independent prognostic information each provides, our findings suggest that if radiologists routinely reported the presence of both CAC and AAC on radiographs of hemodialysis patients, it may help practicing nephrologists identify patients at particularly high risk of death.
Our study has important limitations. The study sample is relatively small. We examined patients at a VA dialysis center; thus, most were men, making the generalizability to women uncertain. Our radiographs were reviewed by a radiologist specializing in thoracic radiology who was specifically examining the images for these calcifications; retrospective review of dictated reports may not reveal these otherwise incidental findings. Concurrent data for chest CT scans or lateral abdominal radiographs are not available, and as such, direct comparison between the relative prevalence, sensitivity, specificity, and strengths of association with mortality by different imaging modalities is unknown. We also were unable to evaluate adjudicated causes of death in our cohort, so we were unable to determine whether cardiovascular mortality in particular was associated with the presence of cardiovascular calcifications.
In summary, chest radiographs, nearly universally available in dialysis patients, are inexpensive, involve low radiation dose, and provide a method for assessing CAC and AAC in hemodialysis patients. Prevalent CAC and AAC are each associated with mortality and both provide information about death risk independent of one another. This simple and ubiquitous imaging modality may hold promise for cardiovascular risk assessment in hemodialysis patients, and as such, calcifications of the aortic arch and coronary arteries should be mentioned specifically by radiologists in their chest radiographic reports.
